Jessica Cotrone | IR |
Balkrishan Gill | President, CEO & Director |
Duncan McHale | Chief Medical Officer |
Mark Bodmer | Chief Scientific Officer & President, Research & Development |
Vikram Purohit | Morgan Stanley |
Chris Shibutani | Cowen and Company |
Na Sun | BMO Capital Markets |
Christopher Howerton | Jefferies |
Good morning, and welcome to Evelo's conference call to discuss the interim clinical data from its Phase Ib trial of EDP1815. [Operator Instructions]. Please be advised that this call is being recorded at the company's request.
At this time, I'd like to turn the call over to Jessica Cotrone of Evelo. Please proceed.